Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples